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correlation between the presence of SV40 viral sequences and the path-
ological type of the tumor since 13 out of the 20 SV40 positive cases 
(65%) were of the sarcomatoid/mixed variants compared to 7 (35%) of 
the epithelioid variant (p.= 0.03). Similarly, there was a statistically sig-
niﬁcant correlation between the presence of SV40 viral sequences and 
a positive history of asbestos exposure (p. = 0.03). Univariate analysis 
showed a signiﬁcant correlation between OS and stage (p= 0.03), 
performance status (p=0.04), p53 overexpression (p=0.05), asbestos 
exposure (p=0.002) and SV40 (p=0.001). Multivariate analysis showed 
that when SV40 and asbestos exposure were considered together, only 
combined positivity of both is an independent prognostic factor affect-
ing the OS (p = 0.001).
Conclusion: SV40 and asbestos exposure are common in Egyptian 
MPM denoting a possible etiological role and a synergistic effect for 
both agents. Our results prove that combined positivity for SV40 and 
asbestos exposure is an independent prognostic factor in MPM having 
a detrimental effect on OS
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Objective: To discuss the clinical presentation, diagnosis and treatment 
of endotracheal/endobrocnchial metastases (EEM). 
Methods: Retrospective and follow-up analyses were conducted of 55 
cases of bronchoscopically conﬁrmed EEM. Clinical staging, loca-
tion in the tracheobronchial tree, the number of lesions, treatment and 
prognosis were analyzed. 
Results: The most common neoplasms associated with EEM were 
esophageal carcinoma (50.9%) and gastric cancer (9.1%). Most EEM 
patients presented with cough, hemoptysis, dyspnea, chest pain and 
fever. Abnormal changes on chest X-ray were found in 83.6% cases, 
and CT imageological changes were found in all patients. There were 
29/66 lesions in the trachea, and 37/66 in the bronchus, including 18 in 
the right bronchus and 19 in the left bronchus. Type I EEM accounted 
for 22/66 cases; Type II, 20/66 cases; Type III, 10/66 cases, and Type 
IV, 14/66 cases. The median survival time was 8.1 months. There was 
signiﬁcant difference in survival time between Type IV EEM and the 
other three types.
Conclusion: EEM may occur in the trachea or in the bronchus. 
Flexible bronchoscopy is a valuable tool for the diagnosis of EEM. 
Although there are cases of long survival, the prognosis of EEM is 
generally poor.
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Background: Malignant pleural mesothelioma (MPM) is a rare and 
aggressive cancer. Asbestos ﬁbers exert their well-recognized causative 
effect on MPM through the direct or indirect generation of reactive 
oxygen and nitrogen species. Many genes that encode for xenobiotic 
and oxidative metabolism enzymes are polymorphic, resulting in pos-
sible individual differences in cancer risk. Two previous studies related 
the risk of MPM with few genetic polymorphisms of xenobiotic and 
oxidative metabolism enzymes, as assessed by PCR techniques, gener-
ating the hypothesis that genetic variation may have a role in individual 
susceptibility to MPM. An association study performed in a case-con-
trol setting including 90 MPM patients and 395 referent subjects is 
described. Thirtyﬁve single nucleotide polymorphisms (SNP) in 10 
genes of phase I and 27 SNPs in 8 genes of phase II of the xenobiotic 
metabolism were explored in relation to the risk of MPM. 
Methods: The polymorphisms were analyzed all at once for a given 
sample by a micro-array technique based on the arrayed-primer exten-
sion (APEX) principle. 
Results: After adjusting for multiple comparisons according to the 
Wacholder method, a general lack of statistically signiﬁcant associa-
tion was evident, with the exceptions of CYP1B1 and NAT1. The 
homozygotes carrying the variant R48G within CYP1B1 were found 
at about four-fold increased risk of MPM respect to homozygotes wild 
type (OR=4.22, 95% CI 1.68-10.61, p=0.002). In addition, the ORs 
calculated for the diplotypes showed that there are haplotypes as-
sociated with the risk of MPM. The slow and intermediate acetylator 
phenotypes for NAT1 posed an increased risk of MPM respect to the 
fast acetylator genotype (OR=4.46, 95%CI 1.07-18.63 and OR=2.35, 
95% CI 1.03-5.4, respectively). 
Conclusions: The present study reinforces the hypothesis that the 
acetylator-phenotype plays a role in relation to the etiology of MPM 
and suggests CYP1B1 as a novel risk factor for MPM.
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Background: Malignant pleural mesotheliomas are rare tumours 
involving the pleural lining of the lung, often associated with asbes-
tosis. We offer aggressive tri-modality treatment in carefully selected 
patients, consisting of neoadjuvant chemotherapy (cisplatin and peme-
trexed) followed by extrapleural pneumonectomy followed by adjuvant 
hemithoracic intensity modulated radiotherapy (IMRT). Usually the 
thoracic cavity (TC) becomes completely ﬂuid ﬁlled after surgery and 
is stable throughout treatment. However, in some patients, the TC is 
partially ﬁlled at the beginning and the ﬂuid levels may change during 
radiation. Clearly, increasing the density of the TC contents will tend to 
attenuate the dose delivered (and vice versa). However, the magnitude 
of these effects are not well understood. The aim of this study is to 
investigate the clinical signiﬁcance of these dosimetric effects.
Methods: The patient was planned using the Inverse Planning module 
of the Pinnacle treatment planning system (version 7.6c). Appropri-
